Ameet Sarpatwari

发表的论文12 篇，按出版时间

1. 1
   Physician Understanding and Perceptions of Risk Communication Related to Drugs Covered by Risk Evaluation and Mitigation Strategy ProgramsPharmacoepidemiology and Drug Safety20260
2. 2
   Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy MaterialsDrug Safety20260
3. 3
   Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 PandemicDrug Safety20260
4. 4
   Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational MaterialsDrug Safety20252
5. 5
   Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000–2020Drug Safety20247
6. 6
   Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort StudyDrug Safety20223
7. 7
   A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) ProgramsDrug Safety202114
8. 8
   Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) ProgramDrug Safety20209
9. 9
   Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting SystemDrug Safety201812
10. 10
    Active Surveillance of Follow-on Biologics: A Prescription for UptakeDrug Safety20164